Gene · 2357
Papers4,418
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 4,418
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of disulfidptosis-related genes and immune infiltration in lower-grade glioma. | Open Med (Wars) | 2023 | 37900961 | PubTator, text mining | PubMed |
| Characteristics and prognostic implications of peripheral blood lymphocyte subsets in patients with anti-MDA5 antibody positive dermatomyositis-interstitial lung disease. | BMC Pulm Med | 2023 | 37898737 | PubTator, text mining | PubMed |
| Redrawing Urokinase Receptor (uPAR) Signaling with Cancer Driver Genes for Exploring Possible Anti-Cancer Targets and Drugs. | Pharmaceuticals (Basel) | 2023 | 37895906 | PubTator, text mining | PubMed |
| Immunobiological signatures and the emerging role of SPP1 in predicting tumor heterogeneity, malignancy, and clinical outcomes in stomach adenocarcinoma. | Aging (Albany NY) | 2023 | 37889539 | PubTator, text mining | PubMed |
| Formyl-peptide receptor 2 signalling triggers aerobic metabolism of glucose through Nox2-dependent modulation of pyruvate dehydrogenase activity. | Open Biol | 2023 | 37875162 | PubTator, text mining | PubMed |
| Fused Tetrahydroquinolines Are Interfering with Your Assay. | J Med Chem | 2023 | 37874947 | PubTator, text mining | PubMed |
| Single cell RNA-sequencing analysis reveals that N-acetylcysteine partially reverses hepatic immune dysfunction in biliary atresia. | JHEP Rep | 2023 | 37869073 | PubTator, text mining | PubMed |
| Machine Learning Developed a Programmed Cell Death Signature for Predicting Prognosis, Ecosystem, and Drug Sensitivity in Ovarian Cancer. | Anal Cell Pathol (Amst) | 2023 | 37868825 | PubTator, text mining | PubMed |
| Single-cell profiling reveals immune disturbances landscape and HLA-F-mediated immune tolerance at the maternal-fetal interface in preeclampsia. | Front Immunol | 2023 | 37854606 | PubTator, text mining | PubMed |
| The entanglement of extracellular matrix molecules and immune checkpoint inhibitors in cancer: a systematic review of the literature. | Front Immunol | 2023 | 37854588 | PubTator, text mining | PubMed |
| Recent advances on cyclodepsipeptides: biologically active compounds for drug research. | Front Microbiol | 2023 | 37849925 | PubTator, text mining | PubMed |
| Neutrophil extracellular traps formation and clearance is enhanced in fever and attenuated in hypothermia. | Front Immunol | 2023 | 37849757 | PubTator, text mining | PubMed |
| Development of potent isoflavone-based formyl peptide receptor 1 (FPR1) antagonists and their effects in gastric cancer cell models. | Eur J Med Chem | 2023 | 37839346 | PubTator, text mining | PubMed |
| Neutrophil-Mediated Progression of Mild Cognitive Impairment to Dementia. | Int J Mol Sci | 2023 | 37834242 | PubTator, text mining | PubMed |
| c-Diadem: a constrained dual-input deep learning model to identify novel biomarkers in Alzheimer's disease. | BMC Med Genomics | 2023 | 37833700 | PubTator, text mining | PubMed |
| Persistence is key: unresolved immune dysfunction is lethal in both COVID-19 and non-COVID-19 sepsis. | Front Immunol | 2023 | 37822940 | PubTator, text mining | PubMed |
| Circulating neutrophil anti-pathogen dysfunction in cirrhosis. | JHEP Rep | 2023 | 37822786 | PubTator, text mining | PubMed |
| Identification of novel potential drugs and miRNAs biomarkers in lung cancer based on gene co-expression network analysis. | Genomics Inform | 2023 | 37813634 | PubTator, text mining | PubMed |
| Acute hypoxia elicits prefrontal oxygenation asymmetry in young adults. | Neurophotonics | 2023 | 37808565 | PubTator, text mining | PubMed |
| Identification and validation of FPR1, FPR2, IL17RA and TLR7 as immunogenic cell death related genes in osteoarthritis. | Sci Rep | 2023 | 37803031 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2357/papers?page=20